ORIGINAL ARTICLE
Hypoxia-inducible factor 1α in combination with vascular endothelial growth factor could predict the prognosis of postoperative patients with oesophageal squamous cell cancer
1
Weifang Medical University, Weifang, People’s Republic of China
2
Department of Thoracic Surgery, Jinan Central Hospital Affiliated to Shandong University, Jinan, People’s Republic
of China
3
Department of Medical Examination, Jinan Central Hospital Affiliated to Shandong University, Shandong University, Jinan, Shandong Province, People’s Republic of China
4
Department of Oncology, Jinan Central Hospital Affiliated to Shandong University, Jinan, People’s Republic of China
5
Department of Pathology, Jinan Central Hospital Affiliated to Shandong University, Shandong University, Jinan, Shandong Province, People’s Republic of China
6
Department of Thoracic Surgery, Jinan Central Hospital Affiliated to Shandong University, Shandong University, Jinan, Shandong Province, People’s Republic of China
Submission date: 2018-08-25
Final revision date: 2018-11-08
Acceptance date: 2018-12-23
Publication date: 2019-08-28
Pol J Pathol 2019;70(2):84-90
KEYWORDS
TOPICS
ABSTRACT
The purpose of the study is to investigate the clinicopathological and prognostic features of dual hypoxia-inducible factor 1a (HIF-1a) and vascular endothelial growth factor (VEGF) expression in oesophageal squamous cell carcinoma (OSCC) patients. A total of 73 patients were enrolled in this study. The positive expression of HIF-1a was identified in 69.9% of the cases. Hypoxia-inducible factor 1a expression was correlative with pT (p = 0.008) and pTNM stage (p = 0.002). The positive expression of VEGF was identified in 63.0% of the cases. Vascular endothelial growth factor expression was correlative with pT (p = 0.005), pN (p = 0.045), and pTNM stage (p < 0.05). HIF-1a and VEGF expressions had a significantly positive correlation (p = 0.010). Dual positive expression of HIF-1a and VEGF was identified in 50.7% (37/73) of the cases, and it was significantly correlative with pT (p = 0.025), pN (p = 0.008), and pTNM stage (p = 0.014). The OSCC patients’ 5-year survival rate was correlative with pT (p < 0.05), pN (p < 0.01), pTNM stage (p < 0.01), VEGF expression (p < 0.01), and dual expressions of HIF-1a and VEGF (p < 0.01). Cox regression analysis showed that pN and dual HIF-1a and VEGF expression were independent prognostic factors for the 5-year survival rate of the patients. In conclusion, HIF-1a combined with VEGF could enable us to more accurately predict the prognosis of OSCC patients.
REFERENCES (17)
1.
Ping W, Sun W, Zu Y, et al. Clinicopathological and prognostic significance of hypoxia-inducible factor-1a in esophageal squamous cell carcinoma: a meta-analysis. Tumour Biol 2014; 35: 4401-4409.
2.
Sun ZG, Yu L, Yang F, et al. Mucin 1 expression correlates with metastatic recurrence in postoperative patients with esophageal squamous cell cancer. Pol J Pathol 2016; 67: 384-391.
3.
Kleespies A, Bruns CJ, Jauch KW. Clinical significance of VEGF-A, -C and -D expression in esophageal malignancies. Onkologie 2005; 28: 281-288.
4.
Swartz JE, Pothen AJ, Stegeman I, et al. Clinical implications of hypoxia biomarker expression in head and neck squamous cell carcinoma: a systematic review. Cancer Med 2015; 4: 1101-1116.
5.
Giatromanolaki A, Harris AL. Tumour hypoxia, hypoxia signalling pathways and hypoxia inducible factor expression in human cancer. Anticancer Res 2001; 21: 4317-4324.
6.
Fu Z, Chen D, Cheng H, et al. Hypoxia-inducible factor-1a protects cervical carcinoma cells from apoptosis induced by radiation via modulation of vascular endothelial growth factor and p53 under hypoxia. Med Sci Monit 2015; 21: 318-325.
7.
Peng J, Shao N, Peng H, et al. Prognostic significance of vascular endothelial growth factor expression in esophageal carcinoma: a meta-analysis. J BUON 2013; 18: 398-406.
8.
Katsuta M, Miyashita M, Makino H, et al. Correlation of hypoxia inducible factor-1alpha with lymphatic metastasis via vascular endothelial growth factor-C in human esophageal cancer. Exp Mol Pathol 2005; 78: 123-130.
9.
Ogawa K, Chiba I, Morioka T, et al. Clinical significance of HIF-1alpha expression in patients with esophageal cancer treated with concurrent chemoradiotherapy. Anticancer Res 2011; 31: 2351-2359.
10.
Ogata Y, Fujita H, Yamana H, et al. Expression of vascular endothelial growth factor as a prognostic factor in node-positive squamous cell carcinoma in the thoracic esophagus: long-term follow-up study. World J Surg 2003; 27: 584-589.
11.
Choi JY, Jang KT, Shim YM, et al. Prognostic significance of vascular endothelial growth factor expression and microvessel density in esophageal squamous cell carcinoma: comparison with positron emission tomography. Ann Surg Oncol 2006; 13: 1054-1062.
12.
Zhong H, De Marzo AM, Laughner E, et al. Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases. Cancer Res 1999; 59: 5830-5835.
13.
Sun G, Hu W, Lu Y, et al. A meta-analysis of HIF-1a and esophageal squamous cell carcinoma (ESCC) risk. Pathol Oncol Res 2013; 19: 685-693.
14.
Xu XL, Ling ZQ, Chen W, et al. The overexpression of VEGF in esophageal cancer is associated with a more advanced TMN stage: a meta-analysis. Cancer Biomark 2013; 13: 105-113.
15.
Terashima J, Sampei S, Iidzuka M, et al. VEGF expression is regulated by HIF-1a and ARNT in 3D KYSE-70, esophageal cancer cell spheroids. Cell Biol Int 2016; 40: 1187-1194.
16.
Takala H, Saarnio J, Wiik H, et al. HIF-1a and VEGF are associated with disease progression in esophageal carcinoma. J Surg Res 2011; 167: 41-48.
17.
Kimura S, Kitadai Y, Tanaka S, et al. Expression of hypoxia-inducible factor (HIF)-1alpha is associated with vascular endothelial growth factor expression and tumour angiogenesis in human oesophageal squamous cell carcinoma. Eur J Cancer 2004; 40: 1904-1912.
Share
RELATED ARTICLE
| eISSN: | 2084-9869 |
| ISSN: | 1233-9687 |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
